Ascension and Providence St Joseph could be the US’ next biggest health merger

By Catherine Sturman
Following from CVS Health’s acquisition of Aetna for $69bn, it has now been reported that Ascension Health and Providence St Joseph Health are present...

Following from CVS Health’s acquisition of Aetna for $69bn, it has now been reported that Ascension Health and Providence St Joseph Health are presently in talks to merge and become the largest provider of hospitals in the US.

If the two non-for-profit healthcare providers were to merge, the newly formed group would encompass over 190 hospitals and medical care clinics which would span across the US, surpassing $40bn in revenue.

The providers only overlap in two states at present.

Ascension is presently the largest Catholic healthcare system in the US, with 2,500 healthcare facilities in over 20 states. Providence St Joseph currently operates 50 hospitals and 829 clinics.

Related stories

However, many are raising the question as to how the merger would ultimately benefit patients. Although both are non-profits, and therefore exempted from certain taxes, healthcare costs are rising, limiting patient control and choice to a certain extent within the ongoing management of patient healthcare.

“Mega-mergers like the potential Providence-Ascension merger warrant a significant level of scrutiny and must have a transparent public process,” observed Robin Wyss, secretary-treasurer for SEIU Healthcare 1199NW.

Additionally, any potential merger could result in potential layoffs for both providers.

This is all on top of the growing uncertainties surrounding the US healthcare sector, in the midst of a growing focus on the industry by tech giants, such as Amazon and Apple. Amazon has obtained a number of pharmaceutical licenses to operate in certain US states, which will further disrupt traditional healthcare processes.

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare